We are proud to partner with leading research institutions and innovative companies around the world including the University of Edinburgh, Sanquin Foundation, Stridebio Inc., and Newcastle University.
Strategic Research Collaboration
Our deep knowledge of genetics and biology has allowed Gemini Therapeutics to develop strong working relationships with our partners to redefine diseases and uncover new therapies. Gemini continues to seek strategic relationships with research institutions and biopharmaceutical partners that share our goal of creating and developing genetically based precision therapeutics for patients suffering from AMD and linked disorders.